SCHEMBL7689907

SCHEMBL7689907

O=c1ccc(-c2ccccc2)n[nH]1.[KH]

nearest known ligand 0.96

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.96
LMNA P02545 3/20 0.63
KMT2A Q03164 2/20 0.63
MEN1 O00255 1/20 0.63
GPR119 Q8TDV5 1/20 0.54
PDE3B Q13370 3/20 0.53
PDE3A Q14432 3/20 0.53
MAPT P10636 1/20 0.50
PDE4A P27815 1/20 0.49
PDE4B Q07343 1/20 0.49
PDE4C Q08493 1/20 0.49
PDE4D Q08499 1/20 0.49
POLB P06746 1/20 0.48
RAB9A P51151 1/20 0.48
TP53 P04637 1/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
AKR1B1 P15121 2/20 0.46
HPGD P15428 2/20 0.46
KDM4E B2RXH2 1/20 0.46
BTK Q06187 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL482059 0.98 CYP1A2 (1.00) CYP1A2LMNAKMT2AMEN1GPR119
SCHEMBL3452908 0.87 LMNA (0.80) CYP1A2LMNAKMT2AMEN1GPR119
SCHEMBL8898883 0.83 CYP1A2 (0.73) CYP1A2LMNAKMT2AMEN1GPR119
SCHEMBL10353459 0.83 CYP1A2 (0.74) CYP1A2LMNAKMT2AMEN1GPR119
SCHEMBL11146636 0.82 CYP1A2 (0.71) CYP1A2LMNAKMT2AMEN1GPR119
SCHEMBL1456606 0.79 CYP1A2 (0.67) CYP1A2LMNAKMT2AMEN1GPR119
SCHEMBL9687063 0.79 LMNA (0.69) CYP1A2LMNAKMT2AMEN1GPR119
SCHEMBL1751891 0.79 CYP1A2 (0.68) CYP1A2LMNAKMT2AMEN1PDE3B
SCHEMBL11156334 0.79 CYP1A2 (0.67) CYP1A2LMNAKMT2AMEN1PDE3B
SCHEMBL10354174 0.78 CYP1A2 (0.67) CYP1A2LMNAKMT2AMEN1GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6413966-B1 SEROTONERGIC AND CENTRAL DOPAMINERGIC ACTIVITY; AFFINITY FOR 5HT1A AND 5HT2 SEROTONIN AND D2 DOPAMINE RECEPTORS; ATYPICAL ANTIPSYCHOTICS; SCHIZOPHRENIA FAES, FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS, S.A. 2002-07-02 US disclosed
EP-1057820-A1 Arylpiperazinylalkyl-3(2H)-pyridazinones as serotonin 5HT and dopamine D2 receptor agonists FAES, Fabrica Espanola de Productos Quimicos y Farmaceuticos, S.A. (ES) 2000-12-06 EP disclosed